nach oben

Annals of Hematology

Erschienen in:

01.01.2007 | Original Article

Frequency of the hemochromatosis gene (HFE) 282C→Y, 63H→D, and 65S→C mutations in a general Mediterranean population from Tarragona, Spain

verfasst von: Núria Aranda, Fernando E. Viteri, Joan Fernández-Ballart, Michelle Murphy, Victoria Arija

Erschienen in: Annals of Hematology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Three mutations have recently been detected in the hereditary hemochromatosis HFE gene (282C→Y, 63H→D, and 65S→C). To determine their prevalence in a northeastern Spanish Mediterranean population, we studied 812 subjects between 18 and 75 years of age, randomly selected from the electoral roll of three villages. There were no homozygotes for the 282C→Y or S65D mutations in this sample. For the 63H→D mutation, 4.8% were homozygotes; 4.3, 32.3, and 2% were heterozygotes for the 282C→Y, 63H→D, and 65S→C mutations, respectively. The prevalence of compound heterozygotes was 2% for 282C→Y/63H→D and 0.6% for 63H→D /65S→C. We found no significant differences between men and women. In conclusion, 46% of this Mediterranean population of Spain are carriers of at least one of the three mutations that can increase iron absorption.

Adams PC, Brissot P, Powell LW (2000) EASL international consensus conference on haemochromatosis. J Hepatol 33:485–504PubMedCrossRef

Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively, Holup JL, Thomson E, Sholinsky P (2005) Hemochromatosis and iron-overload. Screening in a racially diverse population. N Engl J Med 352:1769–1778PubMedCrossRef

Alvarez S, Mesa MS, Bandres F, Arroyo E (2001) C282Y and H63D mutation frequencies in a population from central Spain. Dis Markers 17:111–114PubMed

Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT (1999) Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 25:147–155PubMedCrossRef

Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT (2004) Allele frequencies of hemojuvelin gene (HJV) I222N and G320 V missense mutations in white and African American subjects from the general Alabama population. BMC Med Genet 5:29PubMedCrossRef

Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000) The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 35:1301–1307PubMedCrossRef

Beutler E, Felitti V, Gelbart T, Ho N (2000) The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 133:329–337PubMed

Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218PubMedCrossRef

Beutler E, Felitti VJ (2003) The clinical penetrance of hereditary hemochromatosis. Hepatology 37:711PubMedCrossRef

10.

Beutler E (2006) Hemochromatosis: genetics and pathophysiology. Annu Rev Med 57:5.1–5.17CrossRef

11.

Bradley LA, Johnson DD, Palomaki GE, Haddow JE, Robertson NH, Ferrie RM (1998) Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen 5:34–36PubMed

12.

Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population implications for screening. Gut 43:830–836PubMedCrossRef

13.

Campbell S, George DK, Robb SD, Spooner R, McDonagh TA, Dargie HJ, Mills PR (2003) The prevalence of haemochromatosis gene mutations in the west of Scotland and their relation to ischaemic heart disease. Heart 89:1023–1026PubMedCrossRef

14.

Cardoso CS, Oliveira P, Porto G, Oberkanins C, Mascarenhas M, Rodrigues P, Kury F, Sousa M (2001) Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the north and south of Portugal. Eur J Hum Genet 9:843–848PubMed

15.

de Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E (2001) HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 9:961–964PubMedCrossRef

16.

Fábrega E, Castro B, Sánchez-Castro L, Benito A, Fernández-Luna JL, Pons-Romero F (1999) Prevalencia de la mutación Cys282Tyr del gen de la hemocromatosis en Cantabria y en los pacientes diagnosticados de hemochromatosis hereditaria. Med Clin (Barc) 112:451–453

17.

Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expresion. J Biol Chem 272:14025–14028PubMedCrossRef

18.

Gordeuk VR, Caleffi A, Corradini E, Ferrara F, Jones RA, Castro O, Onyekwere O, Kittles R, Pignatti E, Montosi G, Garuti C, Gangaidzo IT, Gomo ZA, Moyo VM, Rouault TA, MacPhail P, Pietrangelo A (2003) Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis 31:299–304PubMedCrossRef

19.

Guix P, Picornell A, Parera M, Tomas C, Muncunill J, Castro JA, Rossell J, Vaquer P, Ramon MM, Obrador A (2000) Prevalence of the C282Y mutation for haemochromatosis on the island of Majorca. Clin Genet 58:123–128PubMedCrossRef

20.

Guix P, Picornell A, Parera M, Galmes A, Obrador A, Ramon MM, Castro JA (2002) Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin Genet 61:43–48PubMedCrossRef

21.

Hanson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a huge review. Human genome epidemiology. Am J Epidemiol 154:193–206PubMedCrossRef

22.

Holmströn P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730CrossRef

23.

Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JS, Worwood M (2001) HFE mutations, iron deficiency and overload in 10500 blood donors. Br J Haematol 114:474–484PubMedCrossRef

24.

Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V (1997) A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Hum Genet 100:544–547PubMedCrossRef

25.

Lucotte G, Dieterlen F (2003) A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 31:262–267PubMedCrossRef

26.

McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T (1998) Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene? Br J Haematol 102:1176–1178PubMedCrossRef

27.

Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278PubMedCrossRef

28.

Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al (2000) Geography of the C282Y and H63D mutations. Genet Test 4:183–198PubMedCrossRef

29.

Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47PubMedCrossRef

30.

Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol 83:654–657PubMedCrossRef

31.

Milman N, a Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC (2005) Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Ann Hematol 84:146–149PubMedCrossRef

32.

Mura C, Raguenes O, Férec C (1999) HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implications in mild form of hemochomatosis. Blood 93:2502–2505PubMed

33.

Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724PubMedCrossRef

34.

Pietrangelo A (2004) Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 50:2383–2397CrossRef

35.

Sánchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R (1998) Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 29:725–728PubMedCrossRef

36.

Sánchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R (2003) Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol 38:745–750PubMedCrossRef

37.

Soto L, Vega A, Goyanes V, Valverde D (2000) Hemochromatosis in Galicia (NW Spain): a Celtic influence? Clin Genet 57:454–455PubMedCrossRef

38.

Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS (1997) Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with ß2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 94:12384–12389PubMedCrossRef

39.

Waheed A, Grubb JH, Yan Zhou X, Tomatsu S, Fleming RE, Costaldi ME, Britton RS, Bacon BR, Sly WS (2002) Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 99:3117–3122PubMedCrossRef

40.

Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E (2002) Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clin Proc 77:522–530PubMedCrossRef

Titel: Frequency of the hemochromatosis gene (HFE) 282C→Y, 63H→D, and 65S→C mutations in a general Mediterranean population from Tarragona, Spain
verfasst von: Núria Aranda
Fernando E. Viteri
Joan Fernández-Ballart
Michelle Murphy
Victoria Arija
Publikationsdatum: 01.01.2007
Verlag: Springer-Verlag
Erschienen in: Annals of Hematology / Ausgabe 1/2007
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-006-0179-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss

Combination index of soluble transferrin receptor and mean corpuscular hemoglobin for evaluating iron deficiency in end-stage renal disease

Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation

Unsuspected FDG–PET findings in the follow-up of patients with lymphoma

Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia